お電話でもお問い合わせください
03-5860-2441
Report thumbnail
商品コード IM0912207489EK
出版日 2024/3/2
IMARC
英文142 ページグローバル

次世代シーケンス(NGS)市場予測 - シーケンスタイプ別、製品タイプ別、技術別、用途別、エンドユーザー別、地域別:2024年〜2032年

Next-Generation Sequencing (NGS) Market Report by Sequencing Type (Whole Genome Sequencing, Targeted Resequencing, Whole Exome Sequencing, RNA Sequencing, CHIP Sequencing, De Novo Sequencing, Methyl Sequencing, and Others), Product Type (Instruments, Reagents and Consumables, Software and Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, and Others), Application (Biomarker and Cancer, Drug Discovery and Personalized Medicine, Genetic Screening, Diagnostics, Agriculture and Animal Research, and Others), End-User (Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and Region 2024-2032




全体要約











関連する質問

20.1 Billion USD (2023)

16.2% (2024-2032)

Agilent Technologies, Becton Dickinson and Company, 10x Genomics, BGI Group, Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina Inc., Genewiz, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences, PerkinElmer, Thermo Fisher Scientific, Qiagen N.V., GenapSys Inc.

高齢者人口の増加、慢性疾患の有病率の上昇、液体生検の普及


概要






















目次






















Description






















Table of Contents



























※稀に出版元により価格が改定されている場合がございます。

最近見たレポート









contact
© 2023 ShareFair Inc.